Multiple myeloma (MM) has an incidence of 4.5–6.0 per 100,000 individuals and a median age at diagnosis of 70 years in Europe [ 1 ]. The treatment of MM has advanced rapidly over the past decades, translating into substantial overall survival (OS) improvements [ 1 , 2 ].
No takes yet. Share an insight, caveat, or question.
Klomberg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: